Cardio Diagnostics Holdings, Inc. (CDIO) is a Biotechnology company in the Healthcare sector, currently trading at $1.92. It has a SharesGrow Score of 48/100, indicating a mixed investment profile with 2 out of 7 criteria passed.
Valuation: CDIO trades at a trailing Price-to-Earnings (P/E) of -0.5 (S&P 500 average ~25).
Financials: revenue is $14,825, +581.1%/yr average growth. Net income is $6M (loss), growing at -19.1%/yr. Net profit margin is -43832.5% (negative). Gross margin is -2585.5% (-1001.3 pp trend).
Balance sheet: total debt is $695,619 against $7M equity (Debt-to-Equity (D/E) ratio 0.1, conservative). Current ratio is 9.79 (strong liquidity). Debt-to-assets is 9%. Total assets: $8M.
Analyst outlook: 1 / 1 analysts rate CDIO as buy (100%) — strong consensus.
SharesGrow 7-Criteria breakdown: Value 100/100 (Pass), Growth 58/100 (Partial), Past 0/100 (Fail), Health 67/100 (Partial), Moat 0/100 (Fail), Future 100/100 (Pass), Income 10/100 (Fail).
